ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
2,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3,1,Lichen planus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
4,1,Portal hypertension,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
5,1,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
5,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
6,1,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
7,1,Pemphigus,Bullous conditions,Epidermal and dermal conditions,Skin,N
8,1,Encapsulating peritoneal sclerosis,Peritoneal and retroperitoneal fibrosis and adhesions,Peritoneal and retroperitoneal conditions,Gastr,N
9,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9,2,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
10,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
11,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
11,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
12,1,Blood sodium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
12,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12,3,Hyperglycaemic hyperosmolar nonketotic syndrome,Diabetic complications neurological,Diabetic complications,Metab,N
12,4,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
12,5,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
12,6,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
12,7,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
12,8,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
12,9,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
12,10,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
13,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
13,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
14,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
15,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
16,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
16,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
17,1,Guttate psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
18,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
19,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
19,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
19,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
19,4,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
20,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
21,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
21,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
22,1,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
23,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
24,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
24,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
25,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
26,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
27,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
28,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
29,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
30,1,Peyronie's disease,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
31,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
32,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
32,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
33,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
34,1,Hypoglycaemic coma,Coma states,Neurological disorders NEC,Nerv,Y
34,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
35,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
36,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
36,2,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
37,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
37,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
37,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
38,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
38,2,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
38,3,Prothrombin level decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
38,4,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
39,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
39,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
40,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
41,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
42,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
42,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
43,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
43,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
44,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
44,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
44,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
44,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
45,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
46,1,Pupillary reflex impaired,Pupil disorders,Ocular neuromuscular disorders,Eye,N
46,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
47,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
48,1,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
48,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
49,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
50,1,Hepatocellular injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
50,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
50,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
51,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
51,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
52,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
52,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
52,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
52,4,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
52,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
53,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
54,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
55,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
56,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
56,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
57,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
58,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
58,2,Headache,Headaches NEC,Headaches,Nerv,N
59,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
60,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
61,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,Y
62,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
63,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
63,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
63,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
63,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
64,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
64,2,Seborrhoea,Sebaceous gland disorders,Skin appendage conditions,Skin,N
65,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,Y
66,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
66,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
67,1,Therapeutic response increased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
68,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
69,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
70,1,Tongue disorder,Tongue disorders,Tongue conditions,Gastr,N
71,1,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
72,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
73,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
74,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
75,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
75,2,Coma,Coma states,Neurological disorders NEC,Nerv,N
75,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
75,4,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
75,5,Poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
75,6,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
75,7,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
76,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
77,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
78,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
78,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
79,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
79,2,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
80,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
81,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
82,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
83,1,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
84,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
85,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
85,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
85,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
85,4,Headache,Headaches NEC,Headaches,Nerv,N
85,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
86,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
87,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
87,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
87,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
88,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
89,1,Hepatitis cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
90,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
91,1,Drug withdrawal convulsions,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
92,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
93,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
93,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
93,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
94,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
94,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
95,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
95,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
95,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
95,4,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
96,1,Hepatitis cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
97,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
98,1,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
99,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
100,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
101,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
101,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
102,1,Ejaculation failure,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
103,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
104,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
105,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
105,2,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
106,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
107,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
108,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
108,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
108,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
109,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
109,2,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
110,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
111,1,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
112,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
112,2,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
113,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
114,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
114,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
115,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
116,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
117,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
117,2,Prothrombin level decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
118,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
119,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
119,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
120,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
120,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
121,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
121,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
121,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
122,1,Immunoglobulins abnormal,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
122,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
123,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
123,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
123,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
124,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
125,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
126,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
126,2,Hepatitis cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
127,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
127,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
128,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
129,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
129,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
130,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
130,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
130,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
131,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
132,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
133,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
134,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
135,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
136,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
136,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
137,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
138,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
138,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
139,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
140,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
141,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
141,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
142,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
143,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
143,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
144,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
145,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
146,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
147,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
147,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
148,1,Hepatocellular injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
148,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
149,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
150,1,Lichen planus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
151,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
152,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
153,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
153,2,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
154,1,Hepatitis cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
155,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
156,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
157,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
158,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
159,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
160,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
160,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
161,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
162,1,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
162,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
163,1,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
163,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
164,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
164,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
165,1,Lichenoid keratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
166,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
167,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
168,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
169,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
169,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
170,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
171,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
172,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
173,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
174,1,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
174,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
174,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
175,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
176,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
176,2,Urine analysis abnormal,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
177,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
178,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
178,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
179,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
180,1,Diabetic coma,Coma states,Neurological disorders NEC,Nerv,N
181,1,Migraine,Migraine headaches,Headaches,Nerv,N
182,1,Accommodation disorder,Refractive and accommodative disorders,Vision disorders,Eye,N
182,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
182,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
182,4,Urine analysis abnormal,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
183,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
184,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
185,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
186,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
187,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
187,2,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
187,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
187,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
188,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
189,1,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
190,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
191,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
192,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
193,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
194,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
195,1,Headache,Headaches NEC,Headaches,Nerv,N
195,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
195,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
195,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
196,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
196,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
197,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
197,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
198,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
199,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
200,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
200,2,Mastitis,Breast infections,Infections - pathogen unspecified,Infec,N
200,3,Seborrhoea,Sebaceous gland disorders,Skin appendage conditions,Skin,N
201,1,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
201,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
201,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
202,1,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
202,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
203,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
204,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
204,2,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
204,3,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
205,1,Headache,Headaches NEC,Headaches,Nerv,N
205,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
206,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
206,2,Retroperitoneal fibrosis,Peritoneal and retroperitoneal fibrosis and adhesions,Peritoneal and retroperitoneal conditions,Gastr,N
207,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
208,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
209,1,Retroperitoneal fibrosis,Peritoneal and retroperitoneal fibrosis and adhesions,Peritoneal and retroperitoneal conditions,Gastr,N
210,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
211,1,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
211,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
212,1,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
213,1,Hepatocellular injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
213,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
213,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
214,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
214,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
215,1,Hepatitis cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
216,1,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
217,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
217,2,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
217,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
218,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
219,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
220,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
220,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
220,3,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
221,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
221,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
222,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
223,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
223,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
224,1,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
224,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
224,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
225,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
225,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
226,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
227,1,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
228,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
229,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
229,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
230,1,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
231,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
232,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
233,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
234,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
235,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
235,2,Gravitational oedema,Oedema NEC,General system disorders NEC,Genrl,N
236,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
237,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
238,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
239,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
240,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
240,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,Y
241,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
241,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
242,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
243,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
244,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
245,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
246,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
246,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
247,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
248,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
249,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
249,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
250,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
251,1,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
251,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
252,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
253,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
254,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
255,1,Headache,Headaches NEC,Headaches,Nerv,N
255,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
256,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
257,1,Hepatitis cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
258,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
259,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
260,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
260,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
260,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
261,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
262,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
263,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
264,1,Diabetic coma,Coma states,Neurological disorders NEC,Nerv,N
264,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
264,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
265,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
265,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
266,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
267,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
268,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
269,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
270,1,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
270,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
271,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
272,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
272,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
273,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
274,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
274,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
275,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
276,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
277,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
278,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
278,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
279,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
280,1,Migraine,Migraine headaches,Headaches,Nerv,N
281,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
282,1,Hepatitis cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
283,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
284,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
284,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
284,3,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
285,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
285,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
285,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
286,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
287,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
287,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
288,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
288,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
289,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
290,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
290,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
291,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
292,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
292,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
292,3,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
292,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
293,1,Hypoglycaemic coma,Coma states,Neurological disorders NEC,Nerv,Y
294,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
295,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
296,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
296,2,Heart disease congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
297,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
298,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
299,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
300,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
301,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
301,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
302,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
303,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
304,1,Hypoglycaemic coma,Coma states,Neurological disorders NEC,Nerv,N
305,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
305,2,Haemoglobinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
306,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
306,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
306,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
307,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
307,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
308,1,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
309,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
310,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
310,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
311,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
312,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
312,2,Myelopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
312,3,Vitamin B12 deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
313,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
314,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
314,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
314,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
314,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
315,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
316,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,Y
316,2,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
316,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
317,1,Anuria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
317,2,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
317,3,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
317,4,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
317,5,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
317,6,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
317,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
318,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
319,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
320,1,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
321,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
321,2,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
322,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
322,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
322,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
322,4,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
323,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
323,2,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
324,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
324,2,Gastric neoplasm,Gastrointestinal neoplasms malignancy unspecified NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
324,3,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
325,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
325,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
326,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
327,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
327,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
328,1,Cerebral disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
328,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
328,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
329,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
330,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
331,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
331,2,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
331,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
331,4,Haemophilus infection,Haemophilus infections,Bacterial infectious disorders,Infec,N
331,5,Hepatitis cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
331,6,Hypersensitivity vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
331,7,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
331,8,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
331,9,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
331,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
331,11,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
331,12,Renal vasculitis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
331,13,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
331,14,Toxic skin eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
331,15,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
332,1,Pre-eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
332,2,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
333,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
334,1,Stress urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
335,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
335,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
336,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
336,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
336,3,Anuria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
336,4,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
336,5,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
336,6,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
336,7,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
336,8,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
336,9,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
336,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
337,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
337,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
337,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
338,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
338,2,Macrosomia,General signs and symptoms NEC,General system disorders NEC,Genrl,N
338,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
338,4,Polyhydramnios,Amniotic fluid and cavity disorders of pregnancy NEC,"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
338,5,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
339,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
339,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
339,3,Anuria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
339,4,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
339,5,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
339,6,Blood bicarbonate decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
339,7,Blood pH decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
339,8,Body temperature decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
339,9,Cardiac index increased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
339,10,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
339,11,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
339,12,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
339,13,Mean arterial pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
339,14,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
339,15,PCO2 decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
339,16,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
339,17,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
339,18,Vascular resistance systemic decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
339,19,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
339,20,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
340,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
340,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
341,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
342,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
343,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
344,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
344,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
345,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
345,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
346,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
347,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
347,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
